Cited by 68Cardiovascular Function and Risk FactorsCardiac Valve Diseases and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

The Adverse Impact of Diabetes Mellitus on Left Ventricular Remodeling and Function in Patients With Severe Aortic Stenosis

Open access
Lindman, Brian R., Arnold, Suzanne V., Madrazo, José A., Zajarias, Alan, Johnson, Stephanie N., Pérez, Julio E., Mann, Douglas L.·2011·Circulation: Heart Failure

Abstract

Background—: The diabetic heart exhibits increased left ventricular (LV) mass and reduced ventricular function. However, this relationship has not been studied in patients with aortic stenosis (AS), a disease process that causes LV hypertrophy and dysfunction through a distinct mechanism of pressure overload. The aim of this study was to determine how diabetes mellitus (DM) affects LV remodeling and function in patients with severe AS. Methods and Results—: Echocardiography was performed on 114 patients with severe AS (mean aortic valve area [AVA], 0.6 cm 2 ) and included measures of LV remodeling and function. Multivariable linear regression models investigated the independent effect of DM on these aspects of LV structure and function. Compared to patients without diabetes (n=60), those with diabetes (n=54) had increased LV mass and LV end-systolic and end-diastolic dimensions, and decreased LV ejection fraction (EF) and longitudinal systolic strain (all P <0.01). In multivariable analyses adjusting for age, sex, systolic blood pressure, AVA, body surface area, and coronary disease, DM was an independent predictor of increased LV mass (β=26 g, P =0.01), LV end-systolic dimension (β=0.5 cm, P =0.008), and LV end-diastolic dimension (β=0.3 cm, P =0.025). After also adjusting for LV mass, DM was associated with reduced longitudinal systolic strain (β=1.9%, P =0.023) and a trend toward reduced EF (β=−5%, P =0.09). Among patients with diabetes, insulin use (as a marker of disease severity) was associated with larger LV end-systolic dimension and worse LV function. LV mass was a strong predictor of reduced EF and systolic strain (both P <0.001). Conclusions—: DM has an additive adverse effect on hypertrophic remodeling (increased LV mass and larger cavity dimensions) and is associated with reduced systolic function in patients with AS beyond known factors of pressure overload.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.110.960039

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The pattern and magnitude of LV hypertrophic remodelling in AS are influenced by AS severity and by age, sex, genetic factors, metabolic factors, and coexisting coronary artery disease or hypertension.

    “The pattern and magnitude of LV hypertrophic remodelling is influenced not only by AS severity but also by several other factors including age, sex, genetic factors, metabolic factors and the coexistence of coronary artery disease or hypertension116–119.”

    From Calcific aortic stenosis (2016) · cites this paper as [119]

    The Introduction (page not available in our copy) identifies AS-related pressure overload, blood pressure, and sex as influences on LV remodelling. The Discussion and Conclusion report an additional association with diabetes, a metabolic factor. The paper does not establish genetic factors, age, or coexisting coronary artery disease as influences on the pattern or magnitude of remodelling; it adjusts for age and coronary disease instead. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lindman, B. R., Arnold, S. V., Madrazo, J. A., Zajarias, A., Johnson, S. N., Pérez, J. E., & Mann, D. L.
Affiliations
  • Washington University in St. Louis (US)
  • From the Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, MO.
Venue
Circulation: Heart Failure
Published
2011-05
Volume
4
Issue
3
Pages
286-292
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W1991215013
Cited by
68
References
33
Citations by year
2025: 4 · 2024: 1 · 2023: 9 · 2022: 6 · 2021: 3 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 3 · 2013: 5 · 2012: 5
FWCI
3.51
Type
journal article
Language
en
Open access
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Heart Association
  • National Institutes of Health (KL2TR000450, UL1TR000448, RR024992)
  • National Center for Research Resources (RR-024992, KL2RR024994, UL1RR024992)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetes mellitus, aortic stenosis, left ventricular remodeling, left ventricular hypertrophy, left ventricular mass, left ventricular function, ejection fraction, insulin use, pressure overload, diabetic heart
MeSH terms
Aged, Aged, 80 and over, Aortic Valve Stenosis, Female, Humans, Male, Ultrasonography, Hypertrophy, Left Ventricular, Ventricular Remodeling, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review